Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Range Nuclear Renaissance ETF (NUKZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Range Nuclear Renaissance ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.59 (market cap $4.59B), while Range Nuclear Renaissance ETF trades at $61.87 (market cap $698.21M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 6.6× Range Nuclear Renaissance ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Range Nuclear Renaissance ETF for 17 Days on average.
| DFTX | NUKZ | |
|---|---|---|
Market Cap | $4.59B | $698.21M |
Volume | 2,103,937 | 57,444 |
Sector | Health | Sector/Thematic |
52-Week High | $48.45 | $76.23 |
52-Week Low | $10.68 | $60.23 |
Typical Hold Time | 0 Days | 17 Days |
Enterprise Value | $3.55B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Range Nuclear Renaissance ETF
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →
